Evidence map›Paper›PMID 25662211›Full record

ArticleNucleic acids research2015

Luzp4 defines a new mRNA export pathway in cancer cells.

Nicolas Viphakone, Marcus G Cumberbatch, Michaela J Livingstone, Paul R Heath, Mark J Dickman, James W Catto, Stuart A Wilson

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Nuclear transport proteins: structure, function, and disease relevance.Signal transduction and targeted therapy · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. RNA in cancer.Nature reviews. Cancer · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nicolas ViphakoneDepartment of Molecular Biology and Biotechnology, The University of Sheffield, Firth Court, Western Bank, Sheffield, UK.
Marcus G CumberbatchDepartment of Molecular Biology and Biotechnology, The University of Sheffield, Firth Court, Western Bank, Sheffield, UK Academic Urology Unit, The University of Sheffield, Beech Hill Road, Sheffield, UK.
Michaela J LivingstoneDepartment of Molecular Biology and Biotechnology, The University of Sheffield, Firth Court, Western Bank, Sheffield, UK.
Paul R HeathSheffield Institute for Translational Neuroscience, The University of Sheffield, 385a Glossop Road, Sheffield, UK.
Mark J DickmanDepartment of Chemical and Biological Engineering, The University of Sheffield, Mappin Street, Sheffield, UK.
James W CattoAcademic Urology Unit, The University of Sheffield, Beech Hill Road, Sheffield, UK.
Stuart A WilsonDepartment of Molecular Biology and Biotechnology, The University of Sheffield, Firth Court, Western Bank, Sheffield, UK stuart.wilson@sheffield.ac.uk.
University of Sheffield · GB

Funding

Biotechnology and Biological Sciences Research Council BB/D011795/1Biotechnology and Biological Sciences Research Council BB/E025293/1Wellcome Trust 083130/Z/07/Z
6 · The paper itself

Abstract

Cancer testis antigens (CTAs) represented a poorly characterized group of proteins whose expression is normally restricted to testis but are frequently up-regulated in cancer cells. Here we show that one CTA, Luzp4, is an mRNA export adaptor. It associates with the TREX mRNA export complex subunit Uap56 and harbours a Uap56 binding motif, conserved in other mRNA export adaptors. Luzp4 binds the principal mRNA export receptor Nxf1, enhances its RNA binding activity and complements Alyref knockdown in vivo. Whilst Luzp4 is up-regulated in a range of tumours, it appears preferentially expressed in melanoma cells where it is required for growth.

Indexed as

Antigens, NeoplasmCell LineDNA-Binding ProteinsHumansMelanomaNuclear ProteinsNucleocytoplasmic Transport ProteinsRNA-Binding ProteinsRNA, MessengerRNA TransportTranscription FactorsALYREF protein, humanAntigens, NeoplasmDNA-Binding ProteinsLUZP4 protein, humanNuclear ProteinsNucleocytoplasmic Transport ProteinsNXF1 protein, humanRNA-Binding ProteinsRNA, MessengerTranscription Factors

Identifiers

PMID25662211
PMCPMC4344508
OpenAlexW1969500576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.